Inhibition of nucleoside diphosphate reductase by hydroxybenzohydroxamic acid derivatives.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001487:Basidiomycota / Q000032:analysis; D003854:Deoxyribonucleotides / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004357:Drug Synergism; D006367:HeLa Cells; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology*; D009374:Neoplasms, Experimental / Q000188:drug therapy; D010636:Phenols / Q000494:pharmacology*; D012262:Ribonucleoside Diphosphate Reductase / Q000037:antagonists & inhibitors*; D012264:Ribonucleotide Reductases / Q000037:antagonists & inhibitors*
D000970:Antineoplastic Agents; D003854:Deoxyribonucleotides; D006877:Hydroxamic Acids; D010636:Phenols; D004295:Dihydroxyphenylalanine; D012264:Ribonucleotide Reductases; D012262:Ribonucleoside Diphosphate Reductase